| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |